|
|
| | Angiotensinogen (1-13) (human) (trifluoroacetate salt) Basic information |
| | Angiotensinogen (1-13) (human) (trifluoroacetate salt) Chemical Properties |
| solubility | Water: 1 mg/ml |
| | Angiotensinogen (1-13) (human) (trifluoroacetate salt) Usage And Synthesis |
| Description | Angiotensinogen (1-13) is a synthetic peptide precursor of angiotensin I (Item No. 24737) that corresponds to amino acids 1-13 of endogenous human angiotensinogen.1 It is cleaved by renin at the Leu-Val peptide bond to release angiotensin I, which is then converted to angiotensin II (Item No. 17150) by angiotensin converting enzyme (ACE) and exerts vasoconstrictive properties. Angiotensinogen (1-13) has been used in the production of anti-angiotensinogen monoclonal antibodies.2WARNING This product is not for human or veterinary use. | | References | [1] DUANE A. TEWKSBURY James T Richard A Dart. The amino terminal amino acid sequence of human angiotensinogen[J]. Biochemical and biophysical research communications, 1981, 99 4: Pages 1311-1315. DOI: 10.1016/0006-291x(81)90762-2 [2] H SAWA. Distribution of angiotensinogen in diseased human hearts.[J]. Molecular and Cellular Biochemistry, 1994, 132 1: 15-23. DOI: 10.1007/bf00925670 |
| | Angiotensinogen (1-13) (human) (trifluoroacetate salt) Preparation Products And Raw materials |
|